Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-05-22 @ 6:43 AM
Study NCT ID:
NCT06916494
Status:
RECRUITING
Last Update Posted:
2025-04-10
First Post:
2025-04-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study on Rutin Combined With Tislelizumab and GC (Gemcitabine and Cisplatin) as Neoadjuvant Therapy for Platinum-refractory Muscle-invasive Bladder Cancer
Sponsor:
First Affiliated Hospital of Chongqing Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ZZ2025-070-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None